// App-Quantinova.ai

15444 : Anticoagulation Treatment of Venous Thromboembolism Across the Weight Spectrum: Insights From the Veterans Health Administration

Researchers

Presenter

  • Alexander C Perino

Principal Investigators

  • Jun Fan

  • Mitra Kothari

  • ATIF MOHAMMAD

  • Patrick Hlavacek

  • Gail D Wygant

  • Susan K Schmitt

  • Krishna Pundi

  • Paul A Heidenreich

  • Jennifer Guo

  • Mintu Turakhia

Medical Centers

  • Stanford Cardiovascular Inst, Palo Alto, CA

  • VA Palo Alto Healthcare System, Palo Alto, CA

  • Bristol-Myers Squibb, New York City, NY

  • Pfizer Inc, New York, NY

  • Bristol-Myers Squibb, West Chester, PA

  • VA Palo Alto Health Care System, Menlo Park, CA

  • Stanford Univ, Palo Alto, CA

  • Bristol-Myers Squibb, Lawrenceville, NJ

Locations

  • United States

Companies

  • PharmAbcine Inc.

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

  • Arrhythmia

Biomarkers

  • N/A

Drug/Treatment

  • Fondaparinux sodium

  • Warfarin

  • Heparin

Outcome

  • N/A


Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A